Webinar

2022-06-23 AMR: Vaccines as Tools to Prevent Antimicrobial Resistance - VIDEO

Webinar recording

GVIRF-webinar

You can find more information about "GVIRF-webinar" in the following Hot Topics:

TitleAuthorYearTypeLanguage
2021-10-14 mRNA Vaccine Technologies for Global Health - PRESENTATIONSGVIRF Secretariat2021PresentationEnglish
2021-10-14 mRNA Vaccine Technologies for Global Health - VIDEO (corrected link)GVIRF Secretariat2021WebinarEnglish
2022-03-03 Malaria Vaccine R&D and Immunization: Lessons Learned and Considerations for Global Health Impact - AGENDAGVIRF Secretariat2022PresentationEnglish
2022-03-03 Malaria Vaccine R&D and Immunization Lessons Learned and Considerations for Global Health Impact - VIDEOGVIRF Secretariat2022WebinarEnglish
2022-06-23 Vaccines as Tools to Prevent Antimicrobial Resistance: Advances, challenges, and future development - WEBINAR ANNOUNCEMENTGVIRF Secretariat2022PresentationEnglish
2022-06-23 AMR: Vaccines as Tools to Prevent Antimicrobial Resistance: Advances, challenges, and future development - AGENDAGVIRF Secretariat2022PresentationEnglish
2022-06-23 AMR: Vaccines as Tools to Prevent Antimicrobial Resistance - VIDEOGVIRF Secretariat2022WebinarEnglish, French, Spanish
2022-10-12 Correlates of Protection - VIDEO (corrected link)GVIRF Secretariat2022WebinarEnglish
2023-09-13 Webinar: Vaccine Adjuvants for Global Health - Final AGENDAGVIRF Secretariat2023WebinarEnglish
2023-09-13 Webinar: Vaccine Adjuvants for Global Health - VIDEOGVIRF Secretariat2023WebinarEnglish
2023-09-13 Webinar: Vaccine Adjuvants for Global Health - Session III Access to AdjuvantsGVIRF Secretariat2023PresentationEnglish
2023-09-13 Webinar: Vaccine Adjuvants for Global Health - Session I Global Demand for Vaccine AdjuvantsGVIRF Secretariat2023PresentationEnglish
2023-09-13 Webinar: Vaccine Adjuvants for Global Health - Session II Selection of Adjuvant and Formulation for Vaccine R&D: rational or empirical?GVIRF Secretariat2023PresentationEnglish
2024-0222 GVIRF Webinar: New TB Vaccines for Adults and Adolescents, Progress, Prospects, and Perspectives, February 22, 2024 - ANNOUNCEMENTGVIRF Secretariat2024WebinarEnglish
2024-0222 GVIRF Webinar: New TB Vaccines for Adults & Adolescents: Progress, Prospects and Perspectives; February 22, 2024 - FINAL AGENDAGVIRF Secretariat2024WebinarEnglish
2024-0222 GVIRF Webinar: New TB Vaccines for Adults and Adolescents - VIDEOGVIRF Secretariat2024WebinarEnglish, French, Spanish
2024-0222 GVIRF Webinar: New Tuberculosis Vaccines for Adults and Adolescents: Progress, Prospects, and Perspectives - PRESENTATIONSGVIRF Secretariat, Richard White, Nebiat Gebreselassie, Mark Hatherill, Ann Ginsberg, Nicole Frahm, Munyaradzi Musvosvi, David Lewinsohn, Shelly Malhotra, Rupali Limaye, Birgitte Giersing2024PresentationEnglish
2024-0730 GVIRF Webinar: New Combination Vaccines; July 30, 2024 - AGENDA and REGISTRATION LINKGVIRF Secretariat2024WebinarChinese, English, French, Portuguese, Spanish
2024-0730 GVIRF Webinar: New Combination Vaccines - PRESENTATIONSGVIRF Secretariat2024PresentationEnglish
2024-0730 GVIRF Webinar: New Combination Vaccines - Questions and AnswersGVIRF Secretariat2024WebinarEnglish
2024-0730 GVIRF Webinar: New Combination Vaccines - VIDEO (corrected link)GVIRF Secretariat2024WebinarChinese, English, French, Portuguese, Spanish
2024-1121 GVIRF Webinar: Artificial Intelligence (AI) in Vaccine Research & Development - ANNOUNCEMENT AND REGISTRATION LINKGVIRF Secretariat2024WebinarEnglish
2024-1121 GVIRF Webinar: Artificial Intelligence (AI) in Vaccine Research & Development - VIDEOGVIRF Secretariat2024WebinarEnglish

TN-WEBINAR-2022

TitleAuthorYearTypeLanguage
Capacity Development & Professionalization - Session 4: Lessons Learned in locally-driven supply chain capacity development and learningRebecca Alban, Tiana Ravelonarivo2022WebinarEnglish, French
Capacity Development & Professionalization - Session 3: Communities of Learning: the critical role of country chapters in driving supply chain capacity development and professionalisationJacoob Kuutoume, Walter Proper2022WebinarEnglish, French
Capacity Development & Professionalization - Session 2: Building Leadership & Management Capabilities with Public & Private Sector Collaboration: Country examplePatricia Mupeta Bobo, Kevin Etter, Ronan Terrade2022WebinarEnglish, French
Capacity Development & Professionalization - Session 1: The Critical Role of Health Supply Workforce in Driving Immunization and Health OutcomesBill Keough, Dominique Zwinkels, Michael Egharevba, Mwenge Mwanamwenge2022WebinarEnglish, French
EIR or IIS - How to select the Best Digital Immunization System for your Country Context? - Session 5: Overview of CommCare as an EIR/IIS - The Jamaica use caseAlbert Beckford, Denese Palmer, Jordan Lerner2022WebinarEnglish, French, Spanish
EIR or IIS - How to select the Best Digital Immunization System for your Country Context? - Session 4: Overview of Tamanu as an EIR/IIS - The Samoa use caseMichael Nunan2022WebinarEnglish, French, Spanish
EIR or IIS - How to select the Best Digital Immunization System for your Country Context? - Session 3: Overview of SanteIMS as an EIR/IIS - The Tanzania use caseJohn Richard, Madeline Barber2022WebinarEnglish, French, Spanish
Reaching Zero-Dose Children - Session 4: Urban immunizationIjeoma Agbo, Khawaja Aftab Ahmed, Nassor Mohamed2022WebinarEnglish, French
Digital transformation journey of the national immunization information system in VietnamDang Thi Thanh Huyen, Dao Dinh Sang2022WebinarEnglish
EIR or IIS - How to select the Best Digital Immunization System for your Country Context? - Session 2: Overview of DHIS2 Tracker as an EIR/IIS - The Bangladesh use casePamod Amarakoon, Muhammad Masud Parvez, Mike Frost, Md. Jahid Hossen Shahed2022WebinarEnglish, French, Spanish
Reaching Zero-Dose Children - Session 3: Human Resources for missed communitiesAbdul Jabbar, George Mwinnyaa, Rie Takesue2022WebinarEnglish, French
EIR or IIS - How to select the Best Digital Immunization System for your Country Context? - Session 1: EIR and IIS - An introduction to digital immunization systemsEmily Nicholson, Emmanuel Bayo, Harriet Blest2022WebinarEnglish, French, Spanish
WHO consultation on novel manufacturing technologies for monoclonal antibody production with a focus on infectious diseases for LMICs, part 1/2Erin Sparrow, Richard Isbrucker, Shelly Malhotra, Veysel Kayser, Rip Ballou, Ruth Karron, Mark Klempner, Christopher da Costa2022WebinarEnglish
WHO consultation on novel manufacturing technologies for monoclonal antibody production with a focus on infectious diseases for LMICs, part 2/2Erin Sparrow, Weichang Zhou, Christelle Dagoneau, Mark Emalfarb, Julian Ma, Obadiah Plante, J. Christopher Love, Laura Crowell, Jacqueline Kirchner, Maria-Teresa Gutierrez-Lugo, Eric Pelfrene, Pete Gardner2022WebinarEnglish
Reaching Zero-Dose Children - Session 2: Remote rural settingsLisa Oot, Muhammad Farid, Mukhtar Abdi Shube, Sangwe Clovis Nchinjoh2022WebinarEnglish, French
The impact of smart sensing devices and cloud based technology in advancing Senegal's vaccine supply chainAmy Lo Ndiaye2022WebinarEnglish, French
Reaching Zero-Dose Children - Session 1: Immunization in fragile/conflict affected settingsCarrie Nielsen, Enrique Paz, June Ojukwu, Sara Al-Dahir2022WebinarEnglish, French
Introduction to WHO Session Planning Tool based on established vaccine wastage ratesSouleymane Kone2022WebinarEnglish, French
Early Lessons From Ethiopia in Establishing a Data Triangulation Process to Analyze Immunization Program and Supply Data for Decision MakingAdriana Almiñana, Yohannes Lakew Tefera, Amare Bayeh2022WebinarEnglish
Strategies for optimizing Covid-19 vaccine distribution - Session 4: Management of COVID 19 vaccine expiryBaboucarr Boye, Godiskine Attemenego, Maricel Castro, Zabihullah Kamran2022WebinarEnglish, French
Strategies for optimizing Covid-19 vaccine distribution - Session 3: Risk and mitigation strategies for managing Covid-19 vaccines in the supply chain and CCE strategies usedLeonardo Pealta, Michelle Seidel, Nora Lucia Rodriguez, Pablo Llopis2022WebinarEnglish, French, Spanish
Strategies for optimizing Covid-19 vaccine distribution - Session 2: Verification & traceability of COVID 19 vaccineAnita Sands, Edouard Munyangaju, Enric Jané, Lisa Hedman, Max Kabalisa2022WebinarEnglish, French
Strategies for optimizing Covid-19 vaccine distribution - Session 1: Gender considerations in COVID 19 vaccine rolloutCarla Toko, Sofia de Almeida, Stephanie Shendale2022WebinarEnglish, French
Introduction to WHO equipment inventory and gap analysis toolSolo Kone, Mohammad Shadan, Claude Mangobo, Mojtaba Haghgou, Maricel Castro2022WebinarEnglish, French
The Gavi Alliance New Immunisation Supply Chain StrategyKaran Sagar, Michelle Seidel2022WebinarEnglish, French
2022-06-23 AMR: Vaccines as Tools to Prevent Antimicrobial Resistance - VIDEOGVIRF Secretariat2022WebinarEnglish, French, Spanish
EVM webinar series - Session 4: What does EVM tell us about the evolution of immunization supply chains from 2010 to 2022?Paul Colrain2022WebinarEnglish, French
Informal Discussion of the paper "Finding Children with High Risk of Non-Vaccination in 92 Low and Middle-Income Countries: A Decision Tree Approach"M. Carolina Danovaro, Dan Hogan, Edson Utazi2022WebinarEnglish
EVM webinar series - Session 3: Developing and implementing a continuous improvement plan (cIP)Yoms Ishaku, Olamide Folorunso, John Dadzie2022WebinarEnglish, French
EVM webinar series - Session 2: Planning and delivering an EVM assessment - who, when and how?Dan Brigden2022WebinarEnglish, French
EVM webinar series - Session 1: What is Effective Vaccine Management (EVM) and why is it so important?Souleymane Kone, Michelle Seidel, Olamide Folorunso, Dan Brigden2022WebinarEnglish, French
Pfizer BioNTech COVID-19 Vaccine new formulation: implications on vaccine management, supply chain, and technical assistanceChris Larson, Bryan Richmond, John O’Sullivan, Anahitta Shirzad, Maricel Castro, Souleymane Kone, Michelle Seidel, Jessica Lanyon2022WebinarEnglish, French
Assessing the characteristics of un-/under-vaccinated children in low- and middle-income countries: A multi-level cross-sectional studyEdson Utazi, Dan Hogan2022WebinarEnglish
Effective Vaccine Management (EVM): why is progress so slow?Abdoulaye Djigo, Adama Sawadogo, Modibo Dicko2022WebinarEnglish, French
Introduction to the National Immunization Strategy (NIS)Ulla Griffiths, Nathalie Vande Maele, Martha Velandia, Margherita Ghiselli, Eric Laurent2022WebinarEnglish, French, Portuguese, Spanish
Estimating the costs of a National Immunization Strategy (NIS)Saurabh Agarwal, Charu Garg, Eric Laurent, Ulla Griffiths2022WebinarEnglish, French, Spanish

Added by: Angela Hwang

Added on: 2022-12-07 06:20:42

Hits: 2071